Your browser doesn't support javascript.
loading
Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment.
Ziouziou, Hajer; Andrieu, Claudia; Laurini, Erik; Karaki, Sara; Fermeglia, Maurizio; Oueslati, Ridha; Taieb, David; Camplo, Michel; Siri, Olivier; Pricl, Sabrina; Katsogiannou, Maria; Rocchi, Palma.
Afiliação
  • Ziouziou H; Inserm, UMR1068, CRCM, Marseille, France.
  • Andrieu C; Institut Paoli-Calmettes, Marseille, France.
  • Laurini E; Aix-Marseille Université, Marseille, France.
  • Karaki S; CNRS, UMR7258, CRCM, Marseille, France.
  • Fermeglia M; Unit of Immunology Microbiology Environmental and Carcinogenesis (IMEC), Science Faculty of Bizerte, University of Carthage, Bizerte, Tunisia.
  • Oueslati R; Inserm, UMR1068, CRCM, Marseille, France.
  • Taieb D; Institut Paoli-Calmettes, Marseille, France.
  • Camplo M; Aix-Marseille Université, Marseille, France.
  • Siri O; CNRS, UMR7258, CRCM, Marseille, France.
  • Pricl S; Molecular Simulation Engineering (MOSE) Laboratory, DEA, University of Trieste, Trieste, Italy.
  • Katsogiannou M; National Interuniversity Consortium for Material Science and Technology (INSTM), Research Unit MOSE-DEA, University of Trieste, Trieste, Italy.
  • Rocchi P; Inserm, UMR1068, CRCM, Marseille, France.
Oncotarget ; 9(47): 28797, 2018 06 19.
Article em En | MEDLINE | ID: mdl-29983898

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article